Loading…
This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$750K
Filings
13
Firms Hired
1
Active Period
2023–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Sickle Cell Disease Comprehensive Care Act
2026 · third_quarter · Firm: TERUMO BCT, INC.
S.721/H.R. 5178 - Sickle Cell Disease Comprehensive Care Act Blood and cell collection, storage, and processing Blood donation supply and quality
Client expense: $20,000 · Firm income: —
Matched citations: H.R. 5178
Sickle Cell Disease Comprehensive Care Act
2026 · third_quarter · Firm: TERUMO BCT, INC.
S.721/H.R. 5178 - Sickle Cell Disease Comprehensive Care Act Blood and cell collection, storage, and processing Blood donation supply and quality
Client expense: $20,000 · Firm income: —
Matched citations: S.721
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
2026 · second_quarter · Firm: TERUMO BCT, INC.
S.735/H.R. 1796 - Reauthorization of Sickle Cell Disease and Other Heritable Blood Disorders Research, Blood and cell collection, storage, and processing Blood donation supply and quality
Client expense: $20,000 · Firm income: —
Matched citations: H.R. 1796
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
2026 · second_quarter · Firm: TERUMO BCT, INC.
S.735/H.R. 1796 - Reauthorization of Sickle Cell Disease and Other Heritable Blood Disorders Research, Blood and cell collection, storage, and processing Blood donation supply and quality
Client expense: $20,000 · Firm income: —
Matched citations: S.735
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
2026 · first_quarter · Firm: TERUMO BCT, INC.
S.735/H.R. 1796 - Reauthorization of Sickle Cell Disease and Other Heritable Blood Disorders Research, Blood and cell collection, storage, and processing Blood donation supply and quality
Client expense: $20,000 · Firm income: —
Matched citations: H.R. 1796
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
2026 · first_quarter · Firm: TERUMO BCT, INC.
S.735/H.R. 1796 - Reauthorization of Sickle Cell Disease and Other Heritable Blood Disorders Research, Blood and cell collection, storage, and processing Blood donation supply and quality
Client expense: $20,000 · Firm income: —
Matched citations: S.735
Accelerating Kids’ Access to Care Act of 2025
2025 · fourth_quarter · Firm: TERUMO BCT, INC.
S.752/H.R.1509 - Accelerating Kids Access to Care Act S.735/H.R. 1796 - Reauthorization of Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 Blood and cell collection, storage, and processing Blood donation supply and quality
Client expense: $20,000 · Firm income: —
Matched citations: H.R.1509
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
2025 · fourth_quarter · Firm: TERUMO BCT, INC.
S.752/H.R.1509 - Accelerating Kids Access to Care Act S.735/H.R. 1796 - Reauthorization of Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 Blood and cell collection, storage, and processing Blood donation supply and quality
Client expense: $20,000 · Firm income: —
Matched citations: H.R. 1796
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
2025 · fourth_quarter · Firm: TERUMO BCT, INC.
S.752/H.R.1509 - Accelerating Kids Access to Care Act S.735/H.R. 1796 - Reauthorization of Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 Blood and cell collection, storage, and processing Blood donation supply and quality
Client expense: $20,000 · Firm income: —
Matched citations: S.735
Accelerating Kids’ Access to Care Act
2025 · fourth_quarter · Firm: TERUMO BCT, INC.
S.752/H.R.1509 - Accelerating Kids Access to Care Act S.735/H.R. 1796 - Reauthorization of Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 Blood and cell collection, storage, and processing Blood donation supply and quality
Client expense: $20,000 · Firm income: —
Matched citations: S.752
Accelerating Kids’ Access to Care Act of 2025
2025 · third_quarter · Firm: TERUMO BCT, INC.
S.721 - SCD Comprehensive Care Act S.752/H.R.1509 - Accelerating Kids Access to Care Act S.735/H.R. 1796 - Reauthorization of Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 Blood and cell collection, storage, and processing Blood donation supply and quality
Client expense: $20,000 · Firm income: —
Matched citations: H.R.1509
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
2025 · third_quarter · Firm: TERUMO BCT, INC.
S.721 - SCD Comprehensive Care Act S.752/H.R.1509 - Accelerating Kids Access to Care Act S.735/H.R. 1796 - Reauthorization of Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 Blood and cell collection, storage, and processing Blood donation supply and quality
Client expense: $20,000 · Firm income: —
Matched citations: H.R. 1796
Sickle Cell Disease Comprehensive Care Act
2025 · third_quarter · Firm: TERUMO BCT, INC.
S.721 - SCD Comprehensive Care Act S.752/H.R.1509 - Accelerating Kids Access to Care Act S.735/H.R. 1796 - Reauthorization of Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 Blood and cell collection, storage, and processing Blood donation supply and quality
Client expense: $20,000 · Firm income: —
Matched citations: S.721
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
2025 · third_quarter · Firm: TERUMO BCT, INC.
S.721 - SCD Comprehensive Care Act S.752/H.R.1509 - Accelerating Kids Access to Care Act S.735/H.R. 1796 - Reauthorization of Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 Blood and cell collection, storage, and processing Blood donation supply and quality
Client expense: $20,000 · Firm income: —
Matched citations: S.735
Accelerating Kids’ Access to Care Act
2025 · third_quarter · Firm: TERUMO BCT, INC.
S.721 - SCD Comprehensive Care Act S.752/H.R.1509 - Accelerating Kids Access to Care Act S.735/H.R. 1796 - Reauthorization of Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 Blood and cell collection, storage, and processing Blood donation supply and quality
Client expense: $20,000 · Firm income: —
Matched citations: S.752
Accelerating Kids’ Access to Care Act of 2025
2025 · second_quarter · Firm: TERUMO BCT, INC.
S.721 - SCD Comprehensive Care Act S.752/H.R.1509 - Accelerating Kids Access to Care Act S.735/H.R. 1796 - Reauthorization of Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 Blood and cell collection, storage, and processing Blood donation supply and quality
Client expense: $20,000 · Firm income: —
Matched citations: H.R.1509
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
2025 · second_quarter · Firm: TERUMO BCT, INC.
S.721 - SCD Comprehensive Care Act S.752/H.R.1509 - Accelerating Kids Access to Care Act S.735/H.R. 1796 - Reauthorization of Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 Blood and cell collection, storage, and processing Blood donation supply and quality
Client expense: $20,000 · Firm income: —
Matched citations: H.R. 1796
Sickle Cell Disease Comprehensive Care Act
2025 · second_quarter · Firm: TERUMO BCT, INC.
S.721 - SCD Comprehensive Care Act S.752/H.R.1509 - Accelerating Kids Access to Care Act S.735/H.R. 1796 - Reauthorization of Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 Blood and cell collection, storage, and processing Blood donation supply and quality
Client expense: $20,000 · Firm income: —
Matched citations: S.721
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
2025 · second_quarter · Firm: TERUMO BCT, INC.
S.721 - SCD Comprehensive Care Act S.752/H.R.1509 - Accelerating Kids Access to Care Act S.735/H.R. 1796 - Reauthorization of Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 Blood and cell collection, storage, and processing Blood donation supply and quality
Client expense: $20,000 · Firm income: —
Matched citations: S.735
Accelerating Kids’ Access to Care Act
2025 · second_quarter · Firm: TERUMO BCT, INC.
S.721 - SCD Comprehensive Care Act S.752/H.R.1509 - Accelerating Kids Access to Care Act S.735/H.R. 1796 - Reauthorization of Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 Blood and cell collection, storage, and processing Blood donation supply and quality
Client expense: $20,000 · Firm income: —
Matched citations: S.752
Accelerating Kids’ Access to Care Act of 2025
2025 · first_quarter · Firm: TERUMO BCT, INC.
S.721 - SCD Comprehensive Care Act S.752/H.R.1509 - Accelerating Kids Access to Care Act S.735/H.R. 1796 - Reauthorization of Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 Blood and cell collection, storage, and processing Blood donation supply and quality
Client expense: $20,000 · Firm income: —
Matched citations: H.R.1509
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
2025 · first_quarter · Firm: TERUMO BCT, INC.
S.721 - SCD Comprehensive Care Act S.752/H.R.1509 - Accelerating Kids Access to Care Act S.735/H.R. 1796 - Reauthorization of Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 Blood and cell collection, storage, and processing Blood donation supply and quality
Client expense: $20,000 · Firm income: —
Matched citations: H.R. 1796
Sickle Cell Disease Comprehensive Care Act
2025 · first_quarter · Firm: TERUMO BCT, INC.
S.721 - SCD Comprehensive Care Act S.752/H.R.1509 - Accelerating Kids Access to Care Act S.735/H.R. 1796 - Reauthorization of Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 Blood and cell collection, storage, and processing Blood donation supply and quality
Client expense: $20,000 · Firm income: —
Matched citations: S.721
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
2025 · first_quarter · Firm: TERUMO BCT, INC.
S.721 - SCD Comprehensive Care Act S.752/H.R.1509 - Accelerating Kids Access to Care Act S.735/H.R. 1796 - Reauthorization of Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 Blood and cell collection, storage, and processing Blood donation supply and quality
Client expense: $20,000 · Firm income: —
Matched citations: S.735
Accelerating Kids’ Access to Care Act
2025 · first_quarter · Firm: TERUMO BCT, INC.
S.721 - SCD Comprehensive Care Act S.752/H.R.1509 - Accelerating Kids Access to Care Act S.735/H.R. 1796 - Reauthorization of Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 Blood and cell collection, storage, and processing Blood donation supply and quality
Client expense: $20,000 · Firm income: —
Matched citations: S.752
Source: Senate LDA